TA · Healthcare

Teva Pharmaceutical Industries Ltd (TEVA)

Drug Manufacturers - Specialty & Generic

Teva Pharmaceutical Industries Ltd (TEVA) is listed on TA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for TEVA

P/E ratio

18.00

Teva Pharmaceutical Industries Ltd (TEVA) — FAQ

What is TEVA's P/E ratio?

The price-to-earnings (P/E) ratio for Teva Pharmaceutical Industries Ltd (TEVA) is 18.00 (data as of 2026-03-22).

Does Teva Pharmaceutical Industries Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Teva Pharmaceutical Industries Ltd (TEVA). Check the MyAverix Finance app for the latest dividend data.

What sector is Teva Pharmaceutical Industries Ltd in?

Teva Pharmaceutical Industries Ltd (TEVA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is TEVA listed on?

TEVA is listed on TA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)